#news #biotech Impel raises $67.5M as it eyes filing for nasal migraine drug

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Impel raises $67.5M as it eyes filing for nasal migraine drug .Impel NeuroPharma’s championing of the nasal delivery route for drugs has been rewarded with a fourth-round financing that will help it advance three projects through the clinic.

from FierceBiotech: Biotech https://ift.tt/2rqbh0w